Clinical Trial Update: Ibuprofen in Sepsis Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating ibuprofen for sepsis, including septic shock and acute respiratory distress syndrome, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome
• Sepsis
• Septic Shock

Drugs mentioned

• Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Vanderbilt University | Conditions: Acute Respiratory Distress Syndrome, Lung Diseases | Phase 3 | Status: COMPLETED